VC mega-funds are back with General Catalyst, Spark rumored to be raising billions
General Catalyst is said to be raising $10 billion and Spark Capital $3 billion. This after several other firms have also raised mega-funds.
Fundraising
Rivian spin-out Mind Robotics raises $500M for industrial AI-powered robots
The startup, which was created by Rivian founder RJ Scaringe, is looking to train on data from, and deploy in, Rivian’s factory.
Former Apple engineer raises $5M for a note-taking pendant that only records your voice
Taya is trying to address privacy concerns around note-taking wearables with its device that can be worn as a pendant and records only the user’s voice.
Health insurance startup Alan reaches €5B valuation
French health insurance startup Alan is now valued at €5 billion — approximately $5.83 billion, up from $4.5 billion in 2024.
AgentMail raises $6M to build an email service for AI agents
AgentMail provides an API platform that lets you give AI agents their own email inboxes, with support for two-way conversations, parsing, threading, labeling, searching, and replying.
Legora reaches $5.55 billion valuation as AI legal tech boom endures
Legora, an AI platform for lawyers, is now valued at $5.55 billion following a $550 million Series D led by Accel to fuel its growth in the U.S.
Yann LeCun’s AMI Labs raises $1.03 billion to build world models
AMI Labs, the new venture cofounded by Turing Prize winner Yann LeCun after he left Meta, has raised $1.03 billion at a $3.5 billion pre-money valuation.
Zeno raises $25M to speed up production of its battery-swap motorbikes
The startup, co-founded by Tesla and Apple alumni, has sold nearly 1,000 of its motorbikes so far.
Science Corp raises $230M as it races to bring its brain implant to market
A source close to the company says the round assigns Science a post-money valuation of $1.25 billion.
Eight Sleep raises $50M at $1.5B valuation
Eight Sleep said it was free-cash-flow positive in 2025, and plans to use the new funding for new products, global expansions, and clinical validation.